# | Name | Compound Key | Action Type | Relation | Activity Value | Units | Assay ID | Assay Description | Comment | Assay | Assay Organism | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | ALA2333984 | 1beta | IC50 | = | 0.12 | ug ml-1 | ALA2341277 | ug.mL-1 | Homo sapiens | |||
2. | GF109203X | 2b | Activity | < | 5 | % | ALA2341276 | % | Homo sapiens | |||
3. | Dasatinib | 2, BMS-354825 | Activity | = | 95.5 | % | ALA2341276 | % | Homo sapiens | |||
4. | Erlotinib | Tarceva | Activity | = | 7.05 | % | ALA2341276 | % | Homo sapiens | |||
5. | Gefitinib (ZD1839) | Iressa | Activity | < | 5 | % | ALA2341276 | % | Homo sapiens | |||
6. | FASUDIL | HA-1077 | Activity | < | 5 | % | ALA2341276 | % | Homo sapiens | |||
7. | Imatinib (STI571) | 1 | Activity | < | 5 | % | ALA2341276 | % | Homo sapiens | |||
8. | K-252a | 2 (K-252a) | Activity | < | 5 | % | ALA2341276 | % | Homo sapiens | |||
9. | Lapatinib | GW-572016 | Activity | < | 5 | % | ALA2341276 | % | Homo sapiens | |||
10. | PD0166285 | 9 | Activity | 0 | ALA2341276 | Not Determined | Homo sapiens | |||||
11. | ALA608533 | PKC-412 | Activity | < | 5 | % | ALA2341276 | % | Homo sapiens | |||
12. | SB 203580 (DMSO solution) | 9 | Activity | < | 5 | % | ALA2341276 | % | Homo sapiens | |||
13. | Staurosporine | 1 (Staurosporine) | Activity | < | 5 | % | ALA2341276 | % | Homo sapiens | |||
14. | Sunitinib | 12b | Activity | < | 5 | % | ALA2341276 | % | Homo sapiens | |||
15. | AG 1478 | 4 | Activity | = | 24.8 | % | ALA2341276 | % | Homo sapiens | |||
16. | U0126 | U-0126 | Activity | = | 7.55 | % | ALA2341276 | % | Homo sapiens | |||
17. | Vatalanib base | 1 | Activity | < | 5 | % | ALA2341276 | % | Homo sapiens | |||
18. | GF109203X | 2b | Activity | < | 5 | % | ALA2341275 | % | Homo sapiens | |||
19. | Dasatinib | 2, BMS-354825 | Activity | = | 97.1 | % | ALA2341275 | % | Homo sapiens | |||
20. | Erlotinib | Tarceva | Activity | = | 8.15 | % | ALA2341275 | % | Homo sapiens |